Improving the delivery of bone growth proteins using special polymers
Biologic Encapsulation by Tuning their Organic Solubility with Amphiphilic Polymers
This study is looking at a new way to deliver a special protein that helps bones heal better, using advanced materials to make sure it stays safe and works effectively, which could lead to improved treatments for people needing bone regeneration.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rutgers, the State Univ of N.j. NIH-funded |
| Lab location | 1 site (Piscataway, United States) |
| Project ID | NIH-10887177 on NIH RePORTER |
What this research studies
This research focuses on enhancing the delivery of biologic agents, specifically bone morphogenic protein 2 (BMP-2), by using advanced polymers that can better encapsulate these proteins. The team will employ a double emulsion technique to create microparticles that can effectively release BMP-2 in a controlled manner. By fine-tuning the chemistry of the polymers, the researchers aim to protect BMP-2 from degradation and improve its compatibility with the delivery system. This innovative approach may lead to more effective treatments for bone regeneration.
Who could benefit from this research
Good fit: Ideal candidates for this research would include individuals with conditions requiring bone healing or regeneration, such as fractures or bone defects.
Not a fit: Patients with conditions unrelated to bone regeneration or those who do not require surgical intervention may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved therapies for patients needing bone regeneration, potentially enhancing healing and recovery.
How similar studies have performed: Previous research has shown promise in using polymer encapsulation for drug delivery, suggesting that this approach could be effective for biologic agents as well.
Where this research is happening
Piscataway, United States
- Rutgers, the State Univ of N.j. — Piscataway, United States (Active)
Researchers
- Principal investigator: Gormley, Adam Joseph — Rutgers, the State Univ of N.j.
- Study coordinator: Gormley, Adam Joseph
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.